跳至主要内容
临床试验/NCT04665674
NCT04665674招募中不适用

Enquête épidémiologique Sur la prévalence et le Pronostic de l'Histiocytose Langerhansienne Pulmonaire de l'Adulte en France

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2004年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
500
试验地点
1
主要终点
Overall survival

研究概览

简要总结

The long-term outcomes of adult patients with pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, is largely unknown. This is the first prospective study in the field evaluating the long-term outcomes of PLCH patients. This french countrywide registry-based study included a large cohort of PLCH patients followed for a sufficiently long period to address risk factors of long-term outcomes of PLCH patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >= 18 years
  • Diagnosis of PLCH was either histologically confirmed on a biopsy of an involved tissue, or based on the combination of the following criteria: 1) an appropriate clinical picture; 2) a typical nodulo-cystic pattern on lung high-resolution computed tomography (HRCT) and 3) exclusion of alternative diagnoses

排除标准

  • 未提供

结局指标

主要结局

Overall survival

时间窗: 20 years

Overall survival defined as the time from inclusion to death from any cause.

次要结局

  • CRF(20 years)
  • PH(20 years)
  • Malignant diseases(20 years)
  • Extra-pulmonary involvement in isolated PLCH(20 years)
  • Annual prevalence(20 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验